GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » EV-to-EBITDA

Vilin Bio Med (NSE:VILINBIO) EV-to-EBITDA : 17.17 (As of May. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Vilin Bio Med's enterprise value is ₹257.06 Mil. Vilin Bio Med's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹14.97 Mil. Therefore, Vilin Bio Med's EV-to-EBITDA for today is 17.17.

The historical rank and industry rank for Vilin Bio Med's EV-to-EBITDA or its related term are showing as below:

NSE:VILINBIO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 17.03   Med: 47.55   Max: 61.7
Current: 17.17

During the past 3 years, the highest EV-to-EBITDA of Vilin Bio Med was 61.70. The lowest was 17.03. And the median was 47.55.

NSE:VILINBIO's EV-to-EBITDA is ranked worse than
58.23% of 711 companies
in the Drug Manufacturers industry
Industry Median: 14.89 vs NSE:VILINBIO: 17.17

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Vilin Bio Med's stock price is ₹19.15. Vilin Bio Med's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹0.550. Therefore, Vilin Bio Med's PE Ratio for today is 34.82.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Vilin Bio Med EV-to-EBITDA Historical Data

The historical data trend for Vilin Bio Med's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med EV-to-EBITDA Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22
EV-to-EBITDA
- - -

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Sep23
EV-to-EBITDA - - - - -

Competitive Comparison of Vilin Bio Med's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilin Bio Med's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's EV-to-EBITDA falls into.



Vilin Bio Med EV-to-EBITDA Calculation

Vilin Bio Med's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=257.061/14.97
=17.17

Vilin Bio Med's current Enterprise Value is ₹257.06 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vilin Bio Med's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹14.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vilin Bio Med  (NSE:VILINBIO) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Vilin Bio Med's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=19.15/0.550
=34.82

Vilin Bio Med's share price for today is ₹19.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vilin Bio Med's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹0.550.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Vilin Bio Med EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilin Bio Med (NSE:VILINBIO) Business Description

Traded in Other Exchanges
N/A
Address
Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines